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Abstract
Protein signaling is the key method by which cells  recognize a 
stimulus from their environment and convert it into a response. 
Signaling occurs in many forms: hormones, growth factors, 
and even proteins may act as signals from the environment. 
The response to their detection must be carried from the cell 
surface, where the signal is detected, to the nucleus, where 
the cell alters its DNA expression. This study analyzes one 
component in the signaling pathway of Spleen Tyrosine 
Kinase (Syk). The Syk protein receives a signal from B-cell 
receptors and amplifies it, resulting in an adaptive immune 
response and the production of antibodies for targeting  foreign 
 molecules.  Strikingly, constant amplification of the Syk 
signal can transform B-cells into a cancerous phenotype and 
has been  associated with cancers of the lymphatic system. 
Syk has also been implicated in autoimmune diseases such 
as  rheumatoid  arthritis. This study uses nuclear magnetic 
 resonance  spectroscopy to determine the structure of a segment 
from the Syk protein bound to Vav1, a downstream  signaling 
protein that has been implicated in various cancers. The 
preliminary result will be refined using a molecular dynamics 
 simulation to obtain the most energetically stable conformation 
of the protein-ligand interaction. The terminal results of this 
 experiment will reveal the structural details of the Syk-Vav1 
interaction, which may describe a possible therapeutic target in 
the treatment of proliferative B-cell disorders, as well as some 
types of cancer. Using this information, one or more drugs 
may be synthesized to block the interaction in cancerous cells, 
providing a therapeutic avenue to treat the disease.
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InTRODuCTIOn
Purpose of study 
Many serious human disorders are caused by errors 
in cell signaling pathways. Just as a short circuit can 
 induce dysfunction in an electrical system, broken 
 cellular  components can cause improper behavior in a 
cell, which may damage the host organism. The most 
 well-known  example of such a disorder is cancer. Caused 
by a plethora of mutations in the large and complex cell 
signaling  network, cancer is the uncontrolled growth and 
 reproduction of a cell with a broken signaling  pathway. 
The results of this disease can devastate the patient, 
 underscoring the urgent need for continuing cancer research. 
This study models the interaction of proteins in one signal-
ing junction of B-cells. Both proteins modeled have been 
implicated in various cancers when mutated, suggesting 
that a physical structure representing their bound state 
could shed light on a possible method of  cancer treatment.
This experiment models the interaction between Spleen 
Tyrosine Kinase (Syk) and Vav1. Syk is a non-receptor 
 protein tyrosine kinase (Sada, Takano, Yanagi, & 
 Yamamura, 2001); that is, it functions to add a  phosphate 
group to a tyrosine amino acid of another protein. Syk 
is activated upon stimulation of the B-cell receptor. 
Two  major signaling outcomes are Ca2+ release within 
the cell and the activation of the MAP Kinase cascade, 
both  leading to changes in DNA expression and cell 
 morphology (Marx, 1993). 
Vav1 is a multifunctional hub protein. It has several 
components, including a GEF domain for protein  signal 
activation, SRC Homology domains for  mediating 
 interactions with other proteins, and several other 
 domains (Katzav, 2005). Vav1 interacts with Syk via its 
SH2 (SRC Homology 2) domain. This domain has high 
affinity for phosphorylated tyrosine residues.  Because 
tyrosine kinases often autophosphorylate (Murray, 
Padrique, Pinko, & McTigue, 2001), kinase-substrate 
binding via SH2-phosphotyrosine affinity is conserved 
across a spectrum of cellular tyrosine kinases. Despite 
the fact that structures of SH2 domains are known, each 
such domain is specific to one or a few target proteins, 
 requiring a model to be constructed de novo (Birge & 
Hanafusa, 1993). This study may therefore provide useful 
data about the interaction of Syk and Vav1 through Vav1’s 
SH2 domain, which may serve as a basis for rational drug 
design targeting either of the two proteins studied.
The role of Syk kinase in cell signaling
Syk is a non-receptor protein kinase whose activity is 
essential to the clonal expansion of B-cells (Autoimmune 
Diseases, 2010). A crucial immune component, B-cells 
are responsible for producing antibodies. Activation of 
the B-cell receptor by an antigen initiates a signaling 
sequence in which Syk binds to the ITAM protein, which 
induces Syk autophosphorylation. Many downstream 
 proteins in the Syk signal are directly implicated in 
 cellular proliferation, such as Cbl, PLC-γ, PI 3-K, MAP 
Kinase, and Vav1. It is therefore unsurprising that Syk 
regulation is essential for normal cell development and 
transformation into cancer. 
Although most effector proteins in the Syk pathway 
induce cellular proliferation, they differ in their modes 
of action. While inhibition of Syk greatly impedes B-cell 
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 development, disruption of a Syk-substrate interaction 
could have a pathway-specific result. Therefore, the 
structural determination of a Syk-substrate interface could 
provide the necessary information for the synthesis of a 
drug that would normalize cell function. The development 
of such drugs could aid in efforts to combat autoimmune 
diseases such as rheumatoid arthritis.
The polyfunctional protooncogene product Vav1
Vav1 is a hub protein containing multiple domains, each 
with a purpose in signaling. The N-terminal  region 
 contains a CH domain that is used to bind to the  cellular 
scaffold in other proteins. In Vav1, however, it may  regulate 
Ca2+ release (Billadeau & Turner, 2002). The Vav1 DH 
domain is the active site; its GEF activity exchanges GDP 
for GTP in a class of proteins known as GTPases, thereby 
activating them. Neighboring regions in the Vav1 protein 
serve to bind GEF targets to facilitate their activation. The 
remaining region contains a set of conserved sequences 
called SH (SRC Homology) domains, which bind specific 
protein regions. Vav1 contains two SH3 domains, which 
bind to proline-rich motifs. Vav1 binds to Syk via the SH2 
domain residing between the two SH3 regions.
Vav1 has been implicated in cancers via  incorrect 
 localization, overexpression, and overactivation 
 (Billadeau, 2010). Research has shown that expression 
of Vav1 in pancreatic cells results in tumorigenesis in 
this  organ (Fernandez-Zapico, et al., 2005). Similarly, 
 expression of Vav1 in breast tissue may contribute to 
 tumor formation (Lin & Van Golen, 2004). Vav1 is 
 activated through phosphorylation by Syk (Deckert, 
1996). Structural study of the Syk-Vav1 complex may lead 
to rationally designed inhibitors functioning to prevent 
Vav1 activation in cells overexpressing or constitutively 
activating this protein.
The role of nMR spectroscopy in  
structural studies
NMR, or Nuclear Magnetic Resonance spectroscopy, uses 
the magnetic properties of some atomic nuclei (mainly 1H, 
19F, 13C, 15N) to provide information about their through-
bond or through-space  connectivity (NMR  Spectroscopy, 
n.d.). The nuclei involved in these  interactions are 
 characterized by their nonzero spin  quantum number and 
associated nuclear magnetic  moment. In the  presence of 
an external magnetic field, the ensemble of these nuclei 
within the sample generates a net magnetic  moment, 
also called magnetization, which aligns parallel to the 
 applied field. This magnetization can be pictured as 
a vector whose length is governed by the Boltzmann 
 distribution law  applied to nuclear magnetic moments. A 
short  electromagnetic pulse at radiofrequency (RF pulse) 
 perpendicular to the main magnetic field deflects the 
 magnetization  vector from its original direction, causing 
it to rotate.  Information about the structure is gathered 
from the  differing precession speeds of the magnetization 
vectors  belonging to the different types of nuclei, or to 
the same nucleus but in different chemical environments. 
A Fourier transform of the signal induced in the receiver 
coil of the spectrometer by the magnetization allows the 
identification of a characteristic precession frequency for 
each nucleus in the protein.
The utility of the nuclear resonance for chemical and 
biological applications results from the microenvironment 
of the atom. As a magnetic field is imposed upon the 
electrons surrounding the nucleus, they redistribute and 
generate their own field in the opposite direction of the 
applied field. This electron field lowers the strength of the 
total magnetic field acting on the nucleus. This process, 
known as shielding, causes distinct resonant frequencies 
of most atoms in a molecule. Increased shielding decreases 
the necessary energy to flip the nuclear orientation in the 
magnetic field, which lowers the resonance frequency of 
the nucleus. A variety of NMR experiments have been 
devised to aid in assigning each resonance frequency to a 
specific nucleus in a protein. Furthermore, expected reso-
nance frequencies for each atom across all amino acids 
that make up proteins are available in an online database.
Determining the three-dimensional structure of a large 
protein molecule (>1,000 atoms) is challenging. The 
crucial piece of information that NMR is able to resolve is 
the Nuclear Overhauser Effect (NOE), which is a change 
in signal intensity caused by the magnetic interaction 
of two closely spaced nuclei (Gemmecker, 1999). The 
NOE signal depends on distance between two protons (r), 
 specifically on r -6, and is a through-space—as opposed to 
a through-bond—interaction (Wüthrich, 2002). Because 
the effect occurs at the resonance frequency of both inter-
acting nuclei, it can be correlated to known signals. These 
data enable the spectroscopist to obtain distance restraints 
between many pairs of protons within the protein.
While the distance restraints severely limit the  number 
of possible conformations of the polypeptide chain, 
giving it a general shape, the exact conformation of the 
 protein cannot be obtained from NMR data alone. Rather, 
 simulations utilizing molecular mechanics calculate 
 possible conformations consistent with the distance 
restraint data and energy considerations. Generally, the 
correct protein structure has the lowest free energy and 
is therefore in the most thermodynamically stable state. 
However, other methods have been devised that  combine 
energy considerations with other relevant factors to 
 predict the most likely structure (Güntert, 2004).
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MATERIAlS AnD METhODS
Protein isolation
Recombinant E. coli expressing GST-tagged Vav1 SH2 
were cultured in vitro. The bacteria were then lysed using 
a French pressure cell press (French press) and centrifuged 
to separate nuclear and cytoplasmic components. The 
resulting homogenate was filtered and purified using 
an ÄKTA (GE Healthcare) HPLC platform equipped 
with a GST-affinity column. GST was cleaved during 
a  second elution through a His-affinity column after 
 addition of TEV protease. Protein levels during elution 
were  measured using the built-in optical spectrometry 
 capability of the ÄKTA platform and were then confirmed 
using electrophoresis. Purified protein was transported on 
ice for experimentation.
nMR experimentation
A 13-residue peptide homologous in sequence to the 
 SH2-interacting Syk loop was titrated with the purified 
SH2 domain. Following titration, several protein,  carbon, 
and nitrogen NMR experiments were performed for 
chemical shift assignment. Three NOESY spectra were 
also recorded for NOE assignment. All experiments were 
performed on a Bruker Avance-III-800 spectrometer. A 
full list of experiments performed can be found in Table 1.
Chemical shift and dihedral restraint assignment
Assignment of the chemical shifts in the spectrum 
was performed using the program Sparky (Goddard & 
Kneller, 2008). Analysis and assignment of the Vav1 
SH2  15N-HSQC was performed by Dr. Chih-Hong 
Chen. Subsequent chemical shifts were assigned using 
the  15N-HSQC data, as well as standard chemical shift 
values obtained from the Biological Magnetic Resonance 
Bank at the University of Wisconsin (Full Chemical 
Shift  Statistics, 2011). Torsion angle restraints for the 
amino acid backbone were predicted by the program 
TALOS (Shen, Delaglio, Cornilescu, & Bax, 2010) and 
 incorporated into the structure calculation.
nOE assignment and structure calculation
Both NOE peak assignment and protein structure 
 calculation were completed by the program CYANA 
(Güntert, 2004). CYANA is a computational  package that 
constructs protein structures based on the  minimization 
of a target function, which factors in the target  structure’s 
conformity to distance and dihedral restraints. The 
 CYANA modeling function is based on simulated 
 annealing; only torsion angles between atoms are treated 
as degrees of freedom in the calculation, leading to 
reduced computational requirements. CYANA also has 
a built-in NOE assignment routine that dynamically 
communicates with the structure calculation package, 
allowing for on-the-fly selection of peaks based on their 
conformity to an “NOE network” established from trends 
in the peak data.
During initial protein-peptide simulations, no  binding was 
evident in the structure produced by CYANA. CYANA 
either discarded peaks from the filtered  intermolecular 
NOESY spectrum or assigned the peaks to protein, rather 
than to peptide atoms. To combat this,  Piraner NMR 
Suite, an NOE peak labeling  program, was developed in 
C+. This program performed NOE  assignment based on 
chemical shift similarity or  structure-guided constraints 
derived from a template structure. Furthermore, this 
program allowed rapid analysis of the output peak lists to 
determine the source of all assignments. It was discovered 
that out of the 327 peaks identified in the filtered NOESY 
spectrum, 232 could be completely assigned using shifts 
contained only in the protein chemical shift list, while 
only 24 could be assigned using the peptide CS list. This 
poor result can be attributed to a leaky filter and poor 
sensitivity of the filtered TOCSY experiments, which lead 







Aliphatic Side Chain C(CO)NH-TOCSY
Aliphatic Side Chain H(CCO)NH-TOCSY
Aliphatic Side Chain TOCSY-HSQC
Aliphatic Side Chain H(C)CH-TOCSY
Aliphatic Side Chain (H)CCH-TOCSY
Aromatic Side Chain HBCBCGCDHD
Aromatic Side Chain HBCBCGCDCEHE
Aromatic Side Chain 13C-HSQC
Peptide Backbone &  
Side Chain
2D Double-Filtered TOCSY





Intermolecular NOE 3D (13C/15N)-filtered 13C-edited 
NOESY-HSQC
Table 1. Experiments performed on Bruker Avance-III-800 
spectrometer. (Courtesy of Dr. Chih-Hong Chen.)
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NOE and structure refinement
Intermolecular NOEs were picked manually out of the list 
provided by Piraner NMR Suite based on their conformity 
to the projected Syk binding site of the SH2 domain, as 
projected by a previous component of this study. These 
peaks were incorporated into CYANA calculations using 
the KEEP subroutine. The molecular dynamics simulator 
XPLOR-NIH (Schwieters, 2003) refined the CYANA 
structure to obtain the lowest energy conformation.
RESulTS AnD DISCuSSIOn
Sparky data
Chemical shift assignment was initialized from the 
 pre-assigned 2D 15N-HSQC (see Figure 1). This  spectrum 
contained the chemical shifts of the amide nitrogen and 
protons for all residues except 1-3, 15, 38-45  (flexible 
loop), 57, 60-61, and 104. The chemical shifts of other 
 atoms were assigned using the N-HSQC data. The 
 chemical shift coverage of the protein as assigned in 
Sparky was nearly complete; according to the CYANA 
initialization report, 90.6% of the atoms in the protein 
were matched to a chemical shift. 
Chemical shift determination of the peptide was far less 
successful. A combination of a leaky filter and poor 
sensitivity rendered chemical shift assignment difficult. In 
total, 76.8% of the peptide chemicals shifts were assigned. 
This poor coverage likely contributed to the lack of NOE 
restraints generated between the peptide and the protein.
CYAnA calculations
To create a consensus protein structure, two CYANA 
calculations were performed. In the first, CYANA was 
 allowed to select and drop NOE peaks at the discretion 
of its algorithm. In the second, the KEEP subroutine was 
used to preserve the 24 protein-peptide NOE assignments 
generated by Piraner NMR Suite. The CYANA results 
show a precise protein structure being determined, with 
a heavy atom RMSD near one Å. Table 2 displays the 
 calculation statistics for both CYANA runs.
Figure 1. Chemical shift assignment initialized from the pre-assigned 2D 15N-HSQC.
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 The first CYANA calculation resulted in a low RMSD 
and few distance or dihedral restraint violations.  However, 
the resulting structure did not show any association 
between the protein and the peptide. Examination of the 
NOE peaks assigned by CYANA revealed that none of the 
24 intermolecular peaks assigned by Piraner NMR Suite 
had been similarly labeled by the CYANA  NOEassign 
function. This may be attributed to the small amount 
of such peaks. The CYANA  NOEassign routine takes 
“network anchoring” into account. A lack of similar peaks 
would induce the program to treat the intermolecular 
peaks as noise and discard them. The second  calculation 
has many restraint violations in every structure.  However, 
the resulting structure may show the peptide  associating 
with the protein. The structural violations are due to 
 erroneous peak assignment.  Because Piraner NMR Suite 
cannot check the validity of assignment for a  structure 
without a template, it outputs results based solely on 
shift matching of the NOE peaks to the  chemical shift 
library. Furthermore, because some peaks may  correlate 
to the chemical shift of more than one atom, the  program 
 outputs all possible chemical shift  assignments as 
 duplicate peaks. The output peak list contains some 
 impossible combinations, such as duplicate peaks in 
which one copy relates an interaction between a peptide 
atom and an N-terminal protein region, while the other 
contains the same peptide atom and a protein C-terminal 
atom. These discrepancies must be analyzed based on 
 previous work with Vav1 SH2 to remove  impossible 
distance restraints, thereby removing the cause for the 
multitude of restraint violations.
Protein structure output
CYANA generates an ensemble of the 20 structures 
best conforming to the NMR data. Figure 2 shows the 
 structure ensemble for the SH2 domain only. The location 
of the peptide is not visualized. Throughout the structure 
ensemble, some conserved components may be clearly 
seen, including the central β sheet (B) flanked by two α 
helices (A1 & A2) typical of SH2 domains. Other regions 
Table 2. Results of CYANA calculations.
 
Parameter




Extent of assignments 88.5% (of protein + peptide) 88.5% (of protein + peptide)
Number of distance constraints 1499 1681
Number of dihedral restraints 1161 1161
Distance constraint violations 125 3
Dihedral restraint violations 58 0
Average backbone RMSD to mean 1.35 +/- 0.26 Å 0.9 +/- 0.23 Å
Average heavy atom RMSD to mean 1.88 +/- 0.25 Å 1.41 +/- 1.21 Å
Figure 2. Structure ensemble for 
the SH2 domain.
Figure 3. Lack of binding between  
the protein and the peptide in the  
SH2 domain.
Figure 4. The SH2 domain possibly 
bound to the Syk peptide, with restraints 
retained between the protein and peptide.
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of interest include the small, transient flanking β sheet 
(C) and another α helix (D). This overall SH2 structure 
 coincides well with that of SH2-pYpY obtained in an 
 earlier part of this study by Dr. Chen.
Figures 3 and 4 display the same SH2 domain bound to 
the Syk peptide. Unlike in the previous study conducted 
by Dr. Chen, which modeled the interaction between 
Vav1 SH2 and a doubly phosphorylated pYpY peptide, 
this model studies the binding of a singly phosphorylated 
YpY chain. The phosphorylation sites are separated by 
three amino acids, with tyrosines 5 and 9 of the  peptide 
 phosphorylated in the pYpY structure, and only Y9 
phosphorylated in the YpY-bound structure examined in 
the study. Due to the variability in peptide placement in 
the calculations, a full 20 structure ensemble is difficult 
to visualize. Therefore, only the first structures, which 
correspond to the lowest CYANA target functions, are 
visualized in each case.
Figure 3 clearly displays a lack of binding between the 
protein and the peptide. Note that due to the method of 
linking the peptide to the protein used in the CYANA 
calculation, the peptide resembles an extension of the 
SH2 domain. The lack of NOE restraints in this  structure 
combined with a Van der Waals repulsion between 
the protein and peptide lead to a minimization of the 
CYANA target function when the peptide is placed far 
from the protein. Figure 4, in which restraints between 
the protein and peptide are retained, may show some 
 interaction between the protein and peptide. However, 
the large number of  distance and angle violations in this 
structure renders it only a starting point for determination 
of the actual  structure. Manual resolution of the inter-
molecular  distance restraints will enable a true structure 
to be  determined. Figures 5 and 6 display the Van der 
Waals  surface of main chain atoms of the protein and 
 peptide with automatic assignment (Figure 5) and manual 
 assignment (Figure 6).
Further experimentation
Clearly, correct determination of the  protein-peptide 
structure requires manual assignment of the 
 intermolecular NOE peaks. The current  contradictory 
 information leads to far more torsion and distance 
 restraint violations than can be tolerated for a true  protein 
structure. Resolution of the contradictory distance restraints 
will lead to the determination of the correct structure 
of the Vav1-Syk interaction. Refinement of the CYANA 
structure will be performed with XPLOR-NIH. This 
program will use molecular dynamics  computations to 
minimize the energy of the structure created by CYANA. 
Though no drastic alterations are expected, the calcula-
tion may slightly modify some topological features of the 
protein, which are important for interaction with Syk and 
possibly the rest of the Syk-complexed  “signalosome.”
Conclusion
The NMR structure determination of Vav1 SH2 bound 
to the YpY Syk peptide will provide information about 
SH2 binding behavior in this complex. This  information 
could be used to design an inhibitor that would  compete 
with Syk for Vav1 binding, thereby altering the  signaling 
outcome in B-cells. The implication of  constitutively 
Figure 5 and Figure 6. Contact surface of the protein  
and peptide.
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 active Syk and Vav1 in cancer and autoimmune 
 disorders  suggests that such alteration of their  activity 
could  represent a possible avenue in the treatment of 
such  diseases. Once the correct SH2-YpY structure is 
 determined, the difference between it and the pYpY model 
may be used to assess the influence of phosphorylation on 
the structure, possibly providing information leading to 
the development of drugs that counteract excess signaling 
by these two proteins.
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